C-RVV

C:RVV - Revive Therapeutics Ltd. - https://www.revivethera.com

13:28:22 EDT

Sym-X	Bid - Ask					Last	Chg	%Ch	Vol	$Vol	#Tr	Open-Hi-Lo	Year Hi-Lo	Last Tr	News	Delay
RVV - C	100.0	0.015	·	0.02	731.0	0.02	+0.01	100.0	3,283.2	42	86	0.01 0.02 0.01	0.035 0.005	12:46:26	Mar 19	15 min RT 2¢
CSE - C	100.0	0.015	·	0.02	731.0	0.015	+0.005	50.0	2,676.5	34	49	0.01 0.015 0.01	0.035 0.005	12:26:56		15 min
NEO ATS - U						0.02	+0.01	100.0	290.0	4	16	0.015 0.02 0.01		12:46:26		15 min
Omega - O						0.02	+0.01	100.0	50.0	1	4	0.015 0.02 0.015		12:46:26		15 min
Chi-X - X						0.015	+0.005	50.0	17.0	0	1	0.015 0.015 0.015		12:26:56		15 min
CX2 - H						0.02	+0.01	100.0	249.0	3	13	0.015 0.02 0.015		12:46:26		15 min
CXD - D						0.01			0.01		1			Jan 30		15 min
TriAct - M						0.01			0.6		2			Sep 08-20		15 min

Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
NOTE: Delayed ATS trade data is included - click System Status for more information

Show ATS · Fundamentals · Holders · Trade Workstation · Market Depth · 3 Month Closes · Technical Charts 1 yr | 2 yr | 3 yr | 5 yr | 10 yr | 15 yr | 20 yr · Live Charts 1 yr | 1 day · Company · Participants · 1yr Bulletins · Sedar · Historical · Shorts · Portfolio

Recent Trades - Last 10 of 86

More trades...

Time ET	Ex	Price	Change	Volume	Buyer	Seller	Markers
12:46:26	U	0.02	0.01	2,000	1 Anonymous	79 CIBC	K
12:46:26	U	0.02	0.01	10,000	1 Anonymous	79 CIBC	K
12:46:26	H	0.02	0.01	5,000	1 Anonymous	1 Anonymous	K
12:46:26	H	0.02	0.01	2,000	1 Anonymous	1 Anonymous	K
12:46:26	O	0.02	0.01	8,000	1 Anonymous	1 Anonymous	K
12:46:26	H	0.02	0.01	22,000	1 Anonymous	1 Anonymous	K
12:46:26	O	0.02	0.01	1,000	1 Anonymous	2 RBC	K
12:46:25	U	0.02	0.01	2,000	1 Anonymous	79 CIBC	K
12:46:25	U	0.02	0.01	10,000	1 Anonymous	79 CIBC	K
12:33:00	H	0.015	0.005	10,000	1 Anonymous	1 Anonymous	K

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins

News ReleasesIn The NewsOther

Date ET	Symbol	Price	Type	Headline
2025-03-19 17:28	C:RVV	0.01	News Release200	Revive shareholders approve all matters at AGSM
2025-03-03 19:00	C:RVV	0.01	News Release200	Revive to buy molecular hydrogen rights from Diagnamed
2025-02-28 18:44	C:RVV	0.01	SEDAR Interim Financial Statements812	SEDAR Interim Financial Statements
2025-02-28 18:44	C:RVV	0.01	SEDAR Interim MD & A813	SEDAR Interim MD & A
2025-02-03 21:30	C:RVV	0.01	News Release200	Revive to complete Bucillamine study in February
2025-01-08 16:41	C:RVV	0.005	News Release200	Revive Therapeutics talks bucillamine research study
2024-11-29 21:02	C:RVV	0.01	SEDAR Interim MD & A813	SEDAR Interim MD & A
2024-11-29 20:36	C:RVV	0.01	SEDAR Interim Financial Statements812	SEDAR Interim Financial Statements
2024-11-12 15:31	C:RVV	0.01	News Release200	Revive talks BMC article on psilocybin research study
2024-10-31 15:17	C:RVV	0.01	News Release200	Revive expects bucillamine study results by year-end
2024-10-28 15:53	C:RVV	0.01	SEDAR MD & A815	SEDAR MD & A
2024-10-28 15:47	C:RVV	0.01	SEDAR Audited Annual Financial Statements804	SEDAR Audited Annual Financial Statements
2024-09-18 11:52	C:RVV	0.01	News Release200	Revive Therapeutics to focus on bucillamine
2024-08-28 10:21	C:RVV	0.015	News Release200	Revive hopes to complete bucillamine study in October
2024-07-02 15:59	C:RVV	0.01	News Release200	Revive begins bucillamine study on nerve agent exposure
2024-06-12 12:14	C:RVV	0.02	News Release200	Revive receives FDA feedback on Bucillamine study
2024-06-10 11:22	C:RVV	0.02	News Release200	Revive receives FDA feedback for diagnostic device
2024-05-31 01:25	C:RVV	0.025	SEDAR Interim MD & A813	SEDAR Interim MD & A
2024-05-31 01:18	C:RVV	0.025	SEDAR Interim Financial Statements812	SEDAR Interim Financial Statements
2024-04-23 10:17	C:RVV	0.025	News Release200	Revive receives Bucillamine FDA Type C meeting approval